Drp1–FLNA complex formation during hyperlipidemia may facilitate the impairment of FA metabolism through mitochondrial dysfunction, leading to NAFLD progression. The gene discussed is FLNA; the disease is metabolic dysfunction-associated steatotic liver disease.